Navigation Links
Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery
Date:8/31/2010

ter®.  In the PVI group, 500mL of crystalloids were infused at induction, followed by 2mL per kg per hour continuous infusion. A 250mL bolus of colloid was added if the PVI exceeded 13% for more than 5 minutes. In the control group, 500mL of crystalloids were infused at induction, followed by continuous infusion of crystalloids (4 to 8mL per kg per hour) and a 250mL bolus of colloids was given to compensate acute blood losses (>50mL), maintain mean arterial pressure above 65mmHg and the central venous pressure above 6mmHg.  

The results showed that the PVI group received significantly lower amounts of intraoperative crystalloids (P=0.004) and total volume infused (P=0.049), and lactate levels were significantly lower during surgery (1.2 mmol/L +/- 0.6 vs 1.6 +/- 1.2, P=0.04), 24-hours post-operatively (1.4 +/- 0.3 vs 1.8 +/- 1.0, P=0.02), and 48-hour post-operatively (1.2 +/- 0.3 vs 1.4 +/- 0.4, P=0.03).  The researchers concluded that "PVI-based goal directed fluid management reduced the volume of intraoperative fluid infused and reduced both intraoperative and postoperative lactate levels."  Study authors also noted that the reduction in lactate levels for PVI-guided patients suggests that "PVI-guided fluid management may lead to fluid administration that is tailored to each individual patient's needs."

PVI is available as part of Masimo rainbow® SET platform—the first-and-only technology to noninvasively and continuously measure total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), perfusion index (PI), and acoustic respiration rate (RRa™), in addition to the 'gold standard' Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO2), and pulse rate (PR).

"The clinical merit of using a dynamic index like PVI to guide fluid administration relates to a ti
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
3. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
4. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
5. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
8. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
9. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
10. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 /PRNewswire-iReach/ -- "United States General ... key market data on the United ... report provides value, in millions of ... within market categories – Bronchoscopes, Laryngoscopes, ... Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, ...
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud Pharmaceuticals, ... design and development, partnering is an integral part ... to design new drugs and identify early stage, ... to further their development. The company also partners ... support this business model, Cloud Pharmaceuticals will be ...
(Date:9/19/2014)... Sept. 19, 2014  Diplomat, the nation,s largest independent ... Dreyer to the Board of Directors on September ... will also serve as chair of the Audit Committee. ... of accounting, financial, compliance and operating experience in the ... served as chief financial officer, chief operating officer and ...
Breaking Medicine Technology:United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2David Dreyer Appointed to Diplomat Board of Directors 2
... (NASDAQ: SVA ), a leading provider of biopharmaceutical ... results for the period ended June 30, 2011. ... increased 52.5% year-over-year to $15.7 million, compared to $10.3 million. ... EPS was $0.02 per share. Cash and cash ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced ... 2011, as Vice President, Finance and Chief Financial Officer. Mr. ... 13 years before departing in March to work for a ... who has been a key contributor to Arena," said Jack ...
Cached Medicine Technology:Sinovac Reports Unaudited Second Quarter 2011 Financial Results 2Sinovac Reports Unaudited Second Quarter 2011 Financial Results 3Sinovac Reports Unaudited Second Quarter 2011 Financial Results 4Sinovac Reports Unaudited Second Quarter 2011 Financial Results 5Sinovac Reports Unaudited Second Quarter 2011 Financial Results 6Sinovac Reports Unaudited Second Quarter 2011 Financial Results 7Sinovac Reports Unaudited Second Quarter 2011 Financial Results 8Sinovac Reports Unaudited Second Quarter 2011 Financial Results 9Sinovac Reports Unaudited Second Quarter 2011 Financial Results 10Sinovac Reports Unaudited Second Quarter 2011 Financial Results 11Sinovac Reports Unaudited Second Quarter 2011 Financial Results 12Sinovac Reports Unaudited Second Quarter 2011 Financial Results 13Sinovac Reports Unaudited Second Quarter 2011 Financial Results 14Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 2Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 3
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... enabled more generic drugs to inundate the market, thereby ... Pharmaceutical Manufacturing industry. According to data from Industry ... has cost the industry $1.8 and $2.5 billion in ... brand-name drugs losing patent exclusivity, which has hampered revenue ...
(Date:9/21/2014)... September 21, 2014 The Illinois ... will host a statewide symposium ( tinyurl.com/ILBHC14 ) ... and their Families. Sponsored by the VNA Foundation, ... Cash Grant, and Health & Disability Advocates, the ... the Hilton Hotel in Springfield, IL. The ...
(Date:9/21/2014)... -- Young women starting college understand the benefits of ... eat. But they aren,t confident they can follow through ... study. The study involved 268 female college ... Exercising and Eating Right program. The students answered food-related ... if they were very busy with school work, were ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 ... Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 is a ... and Chinese Fenofibrate (CAS 49562-28-9) industry. The ... Fenofibrate (CAS 49562-28-9) including its classification, application ... and China’s top manufacturers of Fenofibrate (CAS ...
(Date:9/21/2014)... An experienced review website in the ... ranking list and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), ... , There has been a boom in websites ... in an increase in the number of web hosting ... very affordable prices. VPS (Virtual Private Server) is the ...
Breaking Medicine News(10 mins):Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
... ... strongest and most effective libido/intimacy enhancement therapy called VaietTM 110/L-Arginine for men and VaietTM ... ... release of their exclusive Viagra/Arginine Intimacy Enhancement Therapy or VAIET (named after their clinical ...
... a deep Michigan tradition of manufacturing to develop ... , DETROIT, June 15 EnovateIT, a national provider of ... internally designed, developed, and assembled Medical Computing Cart ... from admissions and operating rooms to patient rooms - improving ...
... bring colleges and their surrounding neighborhoods together may ... suggests. Researchers found that an alcohol control ... the community -- including increased police patrols in ... parties, combined with efforts to make off-campus students ...
... ... ... June 14, 2009 -- "Thomas McKeever has been selected by Jackson & Coker ... approach to physician staffing at prominent hospitals and large health care organizations across ...
... ... Donor Day , ... 14, 2009 -- Millions of people around the world owe their lives to individuals they will ... a Mercy Ship live and work just minutes away from the patients who receive their "gift ...
... brain damage can occur, , SUNDAY, June 14 (HealthDay News) ... riveted people,s attention to the issue of brain injury and ... to you or a loved one. , Richardson died hours ... resort. She picked herself up from the fall and refused ...
Cached Medicine News:Health News:After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 2Health News:After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 3Health News:After 10 Years A Stronger and More Enhanced Form of Viagra Now Available 4Health News:EnovateIT Announces New Enovate Medical Cart Series 2Health News:EnovateIT Announces New Enovate Medical Cart Series 3Health News:Colleges, communities combat off-campus student drinking 2Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 2Health News:Thomas McKeever to Spearhead Jackson & Coker's National Accounts Division 3Health News:Mercy Ships Celebrates World Blood Donor Day 2Health News:Mercy Ships Celebrates World Blood Donor Day 3Health News:Mercy Ships Celebrates World Blood Donor Day 4Health News:For Every Blow to the Head, Quick Action Is Urged 2Health News:For Every Blow to the Head, Quick Action Is Urged 3
... the advance of digital imaging technology, ... towards digital formats, allowing for easier ... advance in digital pathology imaging is ... in radiology, and which is continuing ...
Inquire...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
Medicine Products: